Literature DB >> 12589027

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.

Wenzhen Duan1, Zhihong Guo, Haiyang Jiang, Melvin Ware, Xiao-Jiang Li, Mark P Mattson.   

Abstract

In addition to neurological deficits, Huntington's disease (HD) patients and transgenic mice expressing mutant human huntingtin exhibit reduced levels of brain-derived neurotrophic factor, hyperglycemia, and tissue wasting. We show that the progression of neuropathological (formation of huntingtin inclusions and apoptotic protease activation), behavioral (motor dysfunction), and metabolic (glucose intolerance and tissue wasting) abnormalities in huntingtin mutant mice, an animal model of HD, are retarded when the mice are maintained on a dietary restriction (DR) feeding regimen resulting in an extension of their life span. DR increases levels of brain-derived neurotrophic factor and the protein chaperone heat-shock protein-70 in the striatum and cortex, which are depleted in HD mice fed a normal diet. The suppression of the pathogenic processes by DR in HD mice suggests that mutant huntingtin promotes neuronal degeneration by impairing cellular stress resistance, and that the body wasting in HD is driven by the neurodegenerative process. Our findings suggest a dietary intervention that may suppress the disease process and increase the life span of humans that carry the mutant huntingtin gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589027      PMCID: PMC151440          DOI: 10.1073/pnas.0536856100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid.

Authors:  Z Guo; A Ersoz; D A Butterfield; M P Mattson
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

2.  Higher sedentary energy expenditure in patients with Huntington's disease.

Authors:  R E Pratley; A D Salbe; E Ravussin; J N Caviness
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

3.  Brain-derived neurotrophic factor in Huntington disease.

Authors:  I Ferrer; E Goutan; C Marín; M J Rey; T Ribalta
Journal:  Brain Res       Date:  2000-06-02       Impact factor: 3.252

4.  Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia.

Authors:  W R Schäbitz; C Sommer; W Zoder; M Kiessling; M Schwaninger; S Schwab
Journal:  Stroke       Date:  2000-09       Impact factor: 7.914

5.  Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease.

Authors:  E Pérez-Navarro; A M Canudas; P Akerund; J Alberch; E Arenas
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

6.  Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.

Authors:  N R Jana; M Tanaka; G h Wang; N Nukina
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

7.  Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.

Authors:  T Nakagawa; A Tsuchida; Y Itakura; T Nonomura; M Ono; F Hirota; T Inoue; C Nakayama; M Taiji; H Noguchi
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

8.  Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer.

Authors:  A P Bemelmans; P Horellou; L Pradier; I Brunet; P Colin; J Mallet
Journal:  Hum Gene Ther       Date:  1999-12-10       Impact factor: 5.695

9.  BDNF regulates eating behavior and locomotor activity in mice.

Authors:  S G Kernie; D J Liebl; L F Parada
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

10.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

View more
  168 in total

1.  Dietary restriction mitigates cocaine-induced alterations of olfactory bulb cellular plasticity and gene expression, and behavior.

Authors:  Xiangru Xu; Mohamed R Mughal; F Scott Hall; Maria T G Perona; Paul J Pistell; Justin D Lathia; Srinivasulu Chigurupati; Kevin G Becker; Bruce Ladenheim; Laura E Niklason; George R Uhl; Jean Lud Cadet; Mark P Mattson
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

2.  Short-term fasting induces profound neuronal autophagy.

Authors:  Mehrdad Alirezaei; Christopher C Kemball; Claudia T Flynn; Malcolm R Wood; J Lindsay Whitton; William B Kiosses
Journal:  Autophagy       Date:  2010-08-14       Impact factor: 16.016

Review 3.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

4.  Effects of diet on synaptic vesicle release in dynactin complex mutants: a mechanism for improved vitality during motor disease.

Authors:  Joel M Rawson; Tabita Kreko; Holly Davison; Rebekah Mahoney; Alex Bokov; Leo Chang; Jon Gelfond; Greg T Macleod; Benjamin A Eaton
Journal:  Aging Cell       Date:  2012-02-22       Impact factor: 9.304

Review 5.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.

Authors:  Danielle A Simmons; Nadia P Belichenko; Tao Yang; Christina Condon; Marie Monbureau; Mehrdad Shamloo; Deqiang Jing; Stephen M Massa; Frank M Longo
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

Review 7.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 8.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

9.  Dietary restriction enhances kainate-induced increase in NCAM while blocking the glial activation in adult rat brain.

Authors:  Sandeep Sharma; Gurcharan Kaur
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

Review 10.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.